Regulatory approvals have focused on weight loss efficacy as the primary endpoint with cardiovascular benefits considered secondary outcomes
The page is for research-only analytical information and provides no dosing, administration, clinical, therapeutic, veterinary, or human-use guidance.
The Bottom Line: What the Evidence Currently Supports The current evidence on Ozempic use during breastfeeding can be summarized as: What we know: Limited research suggests minimal transfer of injectable semaglutide into breast milk, and infants in small studies have shown normal development
Free Radical Biology & Medicine, 95 , 27-42
The link between hair loss and semaglutide is generally associated with rapid metabolic change and reduced calorie intake, rather than any direct damage to the hair follicles themselves
It is crucial to use a new, sterile syringe for each measurement to avoid any contamination or cross-contamination between different experiments
